ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.00
1.57%
Dow Jones
38,239.66
0.40%
Brent Oil
88.165
0.00%
Bitcoin
64,030.68
0.98%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Cartesian Therapeutics Inc (RNAC) Quote

Cartesian Therapeutics Inc

Cartesian Therapeutics Inc (RNAC)

NASDAQ
21.03
0.13
(0.62%)
Closed April 27 4:00PM
Delayed by 15 minutes
21.03
0.00
(0.00%)
After Hours: 5:30PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
21.03
Bid
19.25
Ask
21.79
Volume
123,840
20.71 Day's Range 21.74
11.665 52 Week Range 42.60
Market Cap
3.417B
Previous Close
20.90
Open
20.90
Last Trade
3
@
21.5
Last Trade Time
Financial Volume
$ 2,625,490
VWAP
21.2007
Average Volume (3m)
560,253
Shares Outstanding
161,948,618
Dividend Yield
-
PE Ratio
-15.55
Earnings Per Share (EPS)
-1.36
Revenue
26M
Net Profit
-219.71M

About Cartesian Therapeutics Inc

Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL... Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL-313 for Ornithine Transcarbamylase Deficiency (OTC), and others. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.selectabio.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Cartesian Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RNAC. The last closing price for Cartesian Therapeutics was $20.90. Over the last year, Cartesian Therapeutics shares have traded in a share price range of $ 11.665 to $ 42.60.

Cartesian Therapeutics currently has 161,948,618 shares outstanding. The market capitalization of Cartesian Therapeutics is $3.42 billion. Cartesian Therapeutics has a price to earnings ratio (PE ratio) of -15.55.

RNAC Latest News

More News

Cartesian Therapeutics to Present at the ASGCT 27th Annual Meeting

Cartesian Therapeutics, Inc. (NASDAQ:RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced that recently reported...

April 22 2024
Business Wire

Cartesian Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Cartesian Therapeutics, Inc. (NASDAQ:RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced that its management...

April 04 2024
Business Wire

Cartesian Therapeutics Announces New Employment Inducement Grants

Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company developing mRNA cell therapies for the treatment of autoimmune diseases, today announced the...

April 04 2024
Business Wire

Cartesian Therapeutics Announces Approval of Conversion of Series A Convertible Preferred Stock and Plans to Effect Reverse Stock Split

GAITHERSBURG, Md., March 28, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for...

March 28 2024
GlobeNewswire Inc.

Cartesian Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update

Topline data from Phase 2b study of Descartes-08, the Company’s potential first-in-class mRNA CAR-T cell therapy, in myasthenia gravis (MG) remains on track for mid-2024 On track to initiate...

March 07 2024
GlobeNewswire Inc.

Cartesian Therapeutics to Participate in Upcoming Investor Conferences

GAITHERSBURG, Md., March 06, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ:RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for...

March 06 2024
GlobeNewswire Inc.

Cartesian Therapeutics Announces New Employment Inducement Grant

GAITHERSBURG, Md., March 05, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company developing mRNA cell therapies for the...

March 05 2024
GlobeNewswire Inc.

Cartesian Therapeutics Establishes New Corporate Headquarters and State-of-the-Art mRNA Cell Therapy cGMP Manufacturing Facility in Frederick, Maryland

New facility expected to support expanded cGMP manufacturing of clinical and commercial supply of Company’s pipeline of mRNA cell therapies for the treatment of autoimmune diseases GAITHERSBURG...

March 05 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
13.9523.126463700217.0821.7416.98510675319.99032524CS
41.537.8461538461519.521.7411.66533952316.09935158CS
12-0.642-2.9623477297921.67224.1511.66556025319.3594623CS
26-3.165-13.081215127124.19542.611.66574611923.41872539CS
52-3.165-13.081215127124.19542.611.66574611923.41872539CS
156-3.165-13.081215127124.19542.611.66574611923.41872539CS
260-3.165-13.081215127124.19542.611.66574611923.41872539CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDRXBiodexa Pharmaceuticals PLC
$ 1.3254
(82.86%)
70.82M
IBRXImmunityBio Inc
$ 7.35
(43.84%)
40.28M
AGENAgenus Inc
$ 11.685
(40.78%)
3.37M
ULHUniversal Logistics Holdings Inc
$ 45.63
(38.74%)
484.22k
NIVFNewGenIvf Group Ltd
$ 1.77
(36.15%)
57.78M
MFImF International Ltd
$ 2.3153
(-77.82%)
21.23M
NWGLNature Wood Group Ltd
$ 5.05
(-70.03%)
2.48M
ICLKiClick Interactive Asia Group Ltd
$ 1.21
(-52.17%)
719.95k
NUWENewellis Inc
$ 0.1695
(-41.35%)
18.46M
SGBXSafe and Green Holdings Corporation
$ 0.1469
(-32.92%)
8.39M
PEGYPineapple Energy Inc
$ 0.065499
(26.20%)
325.57M
SQQQProShares UltraPro Short QQQ
$ 11.43
(-4.75%)
137.28M
INTCIntel Corporation
$ 31.88
(-9.20%)
119.84M
TSLATesla Inc
$ 168.29
(-1.11%)
109.84M
SOFISoFi Technologies Inc
$ 7.87
(3.69%)
88.63M

Discussion

View Full Feed
WALLnut WALLnut 1 minute ago
If you only knew. But seriously, let it go.

END OF STORY!
RDGL
ysung ysung 2 minutes ago
What is so pumping about for something that actually happened ???

You confused ?
SPZI
No-Quarter No-Quarter 2 minutes ago
Joey B has his hands all over this too. When he first put this ban on place, it was prefaced as a way to fight global warming. Now according to the below video, the story is 'red tape'. I'm guessing this will be unresolved long enough to keep the ban in place beyond this coming election (to appea
BigB111 BigB111 2 minutes ago
That would take it to like 1.2M OS tgat seems silly when unrestricted is only at 460M
HLLK
Namtro Namtro 2 minutes ago
Yeah but unfortunately, this time CM, this loin puppy won’t be following any normal chart tracking.
$24 milly with Q1 coming soon, I personally would sit this swing out.
But alas, you were right on Friday, 8/7/21, so until you are wrong, I shall step aside.
But please note, I ju
NSAV
tr8dervic tr8dervic 2 minutes ago
McLightning is in with 45 24 10 34
bas2020 bas2020 3 minutes ago
You're long. LOL That's a good one!
NWBO
taggingalong taggingalong 3 minutes ago
That is Hilarious.... You are now trying to tell the Board that before you invested you got the advice or a 'heads up' from 4 different Financial Advisors and you invested a decade or two ago when they had zero revenues quarter to quarter and year to year ..... Well spent money since it has kept you
LQMT
space~farm space~farm 5 minutes ago
I’m long and would be happy if their wild predictions came true and I still fundamentally believe I’ll be able to make it outta this thing alive.

But I think wild valuations of $175 pps in a couple years are less likely than failure lol.
NWBO
misterfishman misterfishman 5 minutes ago
Last post of the night . True that and gn.
IGPK
janice shell janice shell 5 minutes ago
Yes, she certainly did. Apparently she was beginning to suffer health consequences, and decided to do something about it.
HippyTrades HippyTrades 6 minutes ago
"completed in the next three business days."
PSRU
renaissance1 renaissance1 7 minutes ago
Thanks Doc. Hope that happens with in a reasonable time frame. I am a patient man so not a big deal but it would be nice to be rewarded at some point….😂
NWBO
blackhawks blackhawks 7 minutes ago
For quite a while Clarkson looked like she could have subbed for the dancing women in the Ozempic TV ads.
fuagf fuagf 8 minutes ago
Ah, fair enough. In irrationally rushing to judgement i didn't consider the strollers who would have happened along. Yeah, ;-) i very well could have been in that crowd during a fresh air break. And, yep, laughing with the rest of them. My apologies to the crowd. https://www.democraticunderground
BigB111 BigB111 9 minutes ago
Well they'd need to stop dumping so many shares way down here.
EARI
janice shell janice shell 9 minutes ago
That would have been excellent!
Nihil8 Nihil8 9 minutes ago
I bet no filing happens to get us out
CNNA
otterman otterman 10 minutes ago
At least he didnt lie in court.
DBMM
BigB111 BigB111 10 minutes ago
He's a 1st class POS
PDPG
blackhawks blackhawks 10 minutes ago
He could have added, 'I especially enjoyed flying in to our recaptured airfields.' EVERYone would have gotten it.
Nihil8 Nihil8 10 minutes ago
319 days in EM
CNNA
dinogreeves dinogreeves 10 minutes ago
I am already seeing this pattern that is similar to MON*I scam, only this one is a much bigger scam.
SPZI

Your Recent History

NASDAQ
RNAC
Cartesian Therapeutics
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved